Singapore – September 17, 2026 -- Peak3 has launched Graphene Harness, an end-to-end AI-driven delivery lifecycle (AI-DLC) for insurance software, alongside Graphene v4, an AI-native evolution of its core platform, cutting end-to-end new-feature development and core system implementation costs by 50% where deployed.

Delray Beach, Fla. – September 17, 2026 -- The global network automation market is projected to grow from USD 8.69 billion in 2026 to USD 14.42 billion by 2032, a compound annual growth rate of 8.8%, according to MarketsandMarkets. The market stood at USD 7.88 billion in 2025, marking steady acceleration as enterprises replace fragmented manual network operations with centralized, programmable management systems.

Beijing – September 17, 2026 -- A 4-meter hydraulic-electric hybrid humanoid robot capable of carrying a 500 kg dual-arm payload while maintaining fingertip repeatability of ±0.05 mm has been unveiled by Beijing-based NeodraDynamics Robotics at the World Robot Conference (WRC) in Beijing. The machine, named Neo1, combines digital hydraulics with electric actuation, a pairing the company says eliminates the industry's long-standing trade-off between raw force and fine motor precision.

Herndon, Va. – September 17, 2026 -- ST Engineering iDirect is powering satcom integrator Datacom with its Intuition ground system, enabling cloud-native satellite services across the Asia-Pacific region and targeting double-digit reductions in total cost of ownership for Datacom's customers.

Singapore – September 16, 2026 -- Researchers at the National University of Singapore (NUS) have eradicated tumours in 75 per cent of tested preclinical models using pulsed electromagnetic fields (PEMFs) alone, without chemotherapy, after just four 30-minute sessions. The study, led by Associate Professor Alfredo Franco-Obregón of the NUS Yong Loo Lin School of Medicine, was published in the journal Smart Medicine on June 4, 2026.

Shanghai and Hong Kong – September 16, 2026 -- Antengene Corporation Limited (SEHK: 6996.HK) has published preclinical data showing that combining its CD73 inhibitor ATG-037 with selinexor suppressed tumor growth by 62% in a multiple myeloma mouse model, versus 31% for ATG-037 alone and 43% for selinexor alone. The peer-reviewed paper, developed with the Department of Hematology at Peking University Third Hospital, appears in Cancer Gene Therapy, an SCI journal under Springer Nature (DOI: 10.1038/s41417-026-01078-9).

Morristown, N.J. – September 16, 2026 -- Whitehawk Therapeutics (Nasdaq: WHWK) presented real-world data at the IASLC 2026 World Conference on Lung Cancer in Seoul showing that PTK7 expression remains stable in pretreated, EGFR wild-type non-small cell lung cancer (NSCLC), reinforcing the target biology behind its Phase 1 antibody-drug conjugate (ADC) HWK-007.

Seoul – September 16, 2026 -- A phase III trial of tambotatug pelitecan (Tam-Peli, YL201), an anti-B7-H3 antibody-drug conjugate, cut the risk of death by 54% compared with standard-of-care topotecan in patients with relapsed small-cell lung cancer (SCLC), according to data presented at the IASLC 2026 World Conference on Lung Cancer.

Seoul – September 16, 2026 -- Risvutatug rezetecan (Ris-Rez), a B7-H3-directed antibody-drug conjugate, reduced the risk of death by 54% compared with topotecan in patients with relapsed small-cell lung cancer, according to Phase III ARTEMIS-008 trial results presented at the IASLC 2026 World Conference on Lung Cancer.

Seoul – September 16, 2026 -- Hyundai Motor Group has put its "Data Flywheel" system into full operation, converting real-world driving data from an annual fleet of 7 million vehicles sold across the Group into continuous AI training and validation cycles for autonomous driving technology.